Abstract-Proliferation of mammalian cardiomyocytes ceases around birth when a transition from hyperplastic to hypertrophic myocardial growth occurs. Previous studies demonstrated that directed expression of the transcription factor E2F1 induces S-phase entry in cardiomyocytes along with stimulation of programmed cell death. Here, we show that directed expression of E2F2 and E2F4 by adenovirus mediated gene transfer in neonatal cardiomyocytes induced S-phase entry but did not result in an onset of apoptosis whereas directed expression of E2F1 and E2F3 strongly evoked programmed cell death concomitant with cell cycle progression. , which drops to 45% on onset of cardiomyocyte differentiation. 1 Around birth, a transition from hyperplastic to hypertrophic myocardial growth occurs, and cytokinesis and cell proliferation, which are hallmarks of fetal development, are superseded by hypertrophy and binucleation of cardiomyocytes. 2 The proliferation block of cardiomyocytes prevents efficient replacement of functional myocardial on tissue damage, although some reports demonstrated division of cardiomyocytes in the failing heart, indicating that cardiomyocytes retain at least some proliferative capacity 3 The mammalian cell cycle is tightly regulated by a complex network of factors that either promote cell cycle progression or arrest cells at a certain cycle position. Stimulation by growth factors in proliferating cells leads to formation of complexes of D-type cyclins and cdk2/4 and phosphorylation of pocket proteins such as the retinoblastoma protein (pRb). pRb binds and inactivates E2F transcription factors in its hypophosphorylated form, whereas phosphorylated pRb releases E2Fs, which then activate genes required for nucleotide metabolism and DNA synthesis. 4 In addition to the established role in regulation of cell proliferation, some E2Fs, in particular E2F1 and E2F3, have been shown to induce apoptosis 5 and cause, at least in part, the Rb Ϫ/Ϫ phenotype in mice, which is characterized by excessive apoptosis. 6 The family of E2F transcription factors comprises seven individual members: E2F1 to E2F7. Although E2F1 to E2F5 all have both a DNA binding domain, a dimerization domain, and a transactivating domain (see review 7 ), E2F6 and E2F7 have no transactivating properties. Based on sequence homologies, binding of pocket proteins, and the ability to induce S-phase entry in quiescent cells, E2F1 to 5 can be further distinguished into "activating" E2Fs (E2F1, E2F2, and E2F3) and "repressing" E2Fs although such a classification holds true only to specific experimental setups. 7 Previous studies have demonstrated that activation of E2F1 in cardiomyocytes stimulates DNA synthesis but in parallel increases apoptosis. 8 Because individual members of the E2F family serve distinct roles in different cell types and proapoptotic effects are a special hallmark of E2F1, 5,9 we decided to exploit discrete properties of other E2F family members in control of cell proliferation to overcome the cell cycle block of cardiomyocytes wit...